Management of complex asymmetric deficiency of hard and soft tissue for implant-based rehabilitation
Does port type or wound closure technique influence cosmetic outcomes in laparoscopic pediatric urology procedures?
Management of Malignant Ascites by Indwelling Tunnelled Catheters in Indian Setup: A Case Series
Comparative Evaluation of N-Butyl Cyanoacrylate with Braided Silk Suture after Periodontal Flap Surgery: A Randomized Controlled Trial
Surgical management of true vaginal prolapse in a Mongrel bitch
Healthium Medtech announces the launch of its latest manufacturing facility at the Rohisa Industrial Estate, Ahmedabad
The facility was inaugurated by by Shri Arjunsinh Chauhan, Hon’able Minister for Rural Housing & DevelopmentThe Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.The implants and equipment help in treating soft tissue problems especially in the shoulders and knees including meniscal repairs, ACL reconstruction, ligament reconstruction and repair.Ahmedabad, December 09, 2021Ahmedabad, 09 December 2021: Healthium Medtech Limited (“Company” or “Healthium Medtech”), a global medical devices company focused on surgical, post-surgical and chronic care, today announced the launch of its latest manufacturing facility in Ahmedabad. The facility owned by Uteshiya Medicare, is located at the Rohisa Industrial Estate, and has been licenced by Healthium Medtech to exclusively manufacture its wide range of Arthroscopy products marketed under the brand “Sironix”. The CDSCO certified facility is spread across 70,000 sq ft. Healthium Medtech is India’s largest independent medical devices company and second-largest company overall, in the surgical consumables market , the largest non-captive surgical needles manufacturer globally, by volume and the third-largest company overall in the urology collection devices market in the U.K as of fiscal 2021 .As on 31st March, 2021, one in five surgeries conducted globally, uses a Healthium product. Healthium Medtech currently operates across eight integrated and scaled manufacturing facilities, several of which have global accreditations and registrations including US FDA, CE, ISO and TGA .Of these, seven are located in India spread across Karnataka, Uttar Pradesh, Andhra Pradesh, Tamil Nadu, Maharashtra and now Gujarat, and one in China. Healthium was the 1st Class III medical device company in India to receive a US FDA registration for one of its facilities. The Ahmedabad facility was inaugurated by Shri Arjunsinh Chauhan, Hon’able Minister for Rural Housing & Development. Mr. Anish Bafna, Chief Executive Officer and Managing Director, Healthium Medtech said, “It is with great pleasure that we announce the launch of our 7th manufacturing facility in India, at Ahmedabad. It is our endeavour to create high quality precision- based products, made in India through integrated scaled manufacturing. Arthroscopy is one of the fastest growing orthopaedic procedures in India, accounting for 15-17% of the overall procedures. We have created a patented portfolio of arthroscopy products at Healthium and we are very happy to have found in Uteshiya Medicare, a partner that offers the right environment to boost the manufacturing of our arthroscopy portfolio, while ensuring seamless delivery. I am confident that our broad-based expertise and strategic collaboration with Uteshiya , will help us make an impact in the lives of many.” Mr. Jignesh Uteshiya, Director Uteshiya Medicare, said, “We are excited to have partnered with Healthium Medtech and look forward to manufacturing their patented arthroscopy portfolio in a completely green facility built using recycled materials, with built-in energy efficient systems, rainwater harvesting and onsite renewable energy generation. We are also optimizing and customizing operations for maximum efficiency with stringent quality control processes in place. Our most important capital is the perfect synergy of a green environment, competent talent and the effective use of global know-how through practical application.” Arthroscopy products are used to help treat various knee and shoulder conditions such as anterior cruciate ligament reconstruction, posterior cruciate ligament injuries and other ligament reconstruction and repair and meniscal repair. As per Frost & Sullivan report, the Indian arthroscopy devices market was valued at US$ 18.9 million in 2020, and estimated to reach US$ 47.1 million by 2025, implying a CAGR (2021-2025) of 18.6%. Arthroscopy accounts for 15-17% of total orthopaedic procedures carried out in India, and is one of the fastest growing orthopaedic procedures. The volume of arthroscopy procedures conducted, is likely to triple in the next 5-6 years. Key drivers for growth of procedures include a growing base of arthroscopy centres and practicing specialists.
Healthium Medtech receives US FDA registration for its Sri City manufacturing facility in Andhra Pradesh
The 4th facility from Healthium to receive US FDA registration Bangalore, December 08, 2021 National, 8 December, 2021: Healthium Medtech Limited (“Company” or “Healthium Medtech”) , a global medical devices company focused on surgical, post-surgical and chronic care, today announced that the company has received US FDA (U.S. Food and Drug Administration) registration for its manufacturing facility in Sri City, Andhra Pradesh. Healthium Medtech is India’s largest independent medical devices company in the surgical consumables market, the largest non-captive surgical needles manufacturer globally, by volume and the third largest company overall in the urology collection devices market in the U.K as of fiscal 2021. Based on the focus placed in creating high-quality precision- based medical devices, Healthium’s manufacturing facilities are subjected to rigorous quality control checks and periodic inspections from various regulatory agencies across the world. The accreditation of our manufacturing facilities reiterates our focus towards patient safety and is an essential requirement for our products to be used in the treatment of patients globally. As on 31st March, 2021, one in five surgeries conducted globally, uses a Healthium product. Healthium Medtech operates across eight integrated and scaled manufacturing facilities, several of which have global accreditations and registrations including with US FDA, CE, TGA, CDSCO and ISO. It is the only company in India with a CE-certified surgical needles manufacturing facility as on March 31, 2021.Healthium was the first Class III medical device company in India to receive a US FDA registration for one of its facilities. With this announcement, the Sri City plant becomes the fourth US FDA registered Healthium facility. It also has CDSCO, ISO 9001:2015 and EN ISO 13485: 2016 certifications. Healthium commenced its operations at the Sri City facility in calendar year 2012. The facility manufactures sutures, meshes with a production capacity of 1.20 million, as per the fiscal of 2021, and is located in a special economic zone (SEZ). Speaking on the recent development, Mr. Anish Bafna, Chief Executive Officer and Managing Director, Healthium Medtech said, “We are delighted to receive the US FDA registration for our Sri City facility in Andhra Pradesh, our 4th facility to receive it. This is testimony to our commitment to operational excellence and to our focus in delivering high quality, safe, value driven products aligned with our vision “Access to precision medtech for every patient, globally”
Healthium Medtech introduces surgical wound dressing with patented infection-prevention technology
Healthium Medtech Limited (“Healthium Medtech” or “Healthium”), a global medtech company focused on products used in surgical, post-surgical and chronic care, today announced the launch of TRUSHIELD™ NXT surgical wound dressing, adding to its portfolio of patented products in the wound care and infection prevention segments. In addition to wound care, Healthium’s current product portfolio focusses on advanced surgery, urology and arthroscopy products covering 52,000 stock keeping units. As of fiscal 2021, Healthium is India’s largest independent medical device company and second-largest company overall, in the surgical consumables market. In the non-captive surgical needles segment, it is the largest manufacturer globally, by volume and the third-largest company overall in urology collection devices market in the U.K as on 31st March, 2021. As of fiscal 2021, one in five surgeries conducted globally uses a Healthium product. The announcement comes after Healthium’s acquisition of CareNow Medical last month. As of July 31, 2021, the company has 21 patents in India and 11 patents in the United States, and a further 22 and 6 patent applications pending approval in India and US, respectively. With the acquisition of CareNow, the company has acquired an additional portfolio of one patent each in India, US and Europe and one patent application pending approval in India. TRUSHIELDTM NXT combines the advantages of a 3D hydrocellular substrate and patented infection prevention technology to offer a complete wound care system that provides 360 degree wound protection. It provides exudate and moisture management, while remaining waterproof. Its patented technology continuously inhibits pathogen growth with a unique non-leaching, non-depleting kill mechanism. It has patents in the U.S, Europe and India. The advanced wound care market expected to grow at a CAGR of 8.8%*.Dominated by traditional wound dressing such as cotton gauze, the Advanced wound dressing category has lagged in penetration because of high pricing of products and limited availability.TRUSHIELD™ NXT is non- adherent (does not stick to the wound and can be easily removed) and water proof with exudate management ability when compared to traditional wound dressing and reduces the need to repeatedly change dressings, thereby reducing costs Speaking on the new product launch Anish Bafna, CEO and MD, Healthium Medtech, said, “We are excited to add TRUSHIELD™ NXT to strengthen our wound care and post-surgical care portfolio. Aligned to our vision “Access to precision medtech for every patient, globally”, TRUSHIELD™ NXT is manufactured to high quality standards at our US FDA registered plant. With our sales network reaching 90% of districts in India with secondary healthcare facilities catering to 40,000 surgeons across 18000 hospitals, we look to offering wider choices to our customers and delivering better standards in patient care, with innovative and quality products.” Dr. Ashok Moharana, Chief Medical Officer, Healthium Medtech said “A successful surgery is complemented by a well- healed wound. TRUSHIELD™ NXT surgical wound dressing, enables healing through exudate and moisture management ability while providing infection control with a patented technology that continuously inhibits growth of pathogen ( 99.99% kill rate against a broad spectrum of pathogen). The dressing is water-proof and does not adhere to the wound, for a trauma- less removal. We believe that with this new technology and our access, we will be able to benefit patients globally.” *Frost & Sullivan report
Healthium acquires CareNow, strengthens R&D capabilities and portfolio with differentiated and patented products
Healthium, a global player in medical devices, today announced the successful acquisition of CareNow Medical Private Limited, strengthening its product portfolio with patented and differentiated products in the advanced wound management and infection prevention segments.
Healthium acquires AbGel to strengthen portfolio and expand market presence
Healthium, a global player in medical devices, today announced the successful acquisition of CareNow Medical Private Limited, strengthening its product portfolio with patented and differentiated products in the advanced wound management and infection prevention segments.